HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John McMillan Selected Research

volagidemab

1/2018Effect of a glucagon receptor antibody (REMD-477) in type 1 diabetes: A randomized controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


John McMillan Research Topics

Disease

1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2018
1Dental Caries (Decay, Dental)
11/2014

Drug/Important Bio-Agent (IBA)

1Insulin (Novolin)FDA Link
01/2018
1Glucagon Receptors (Glucagon Receptor)IBA
01/2018
1volagidemabIBA
01/2018
1FluoridesIBA
11/2014

Therapy/Procedure

1Fluoridation
11/2014